Dimensionality Reduction based Transfer Learning applied to Pharmacogenomics Databases

Recent years have observed a number of Pharmacogenomics databases being published that enable testing of various predictive modeling techniques for personalized therapy applications. However, the consistencies between the databases are usually limited in spite of having significant number of common...

Full description

Saved in:
Bibliographic Details
Published in:2018 40th Annual International Conference of the IEEE Engineering in Medicine and Biology Society (EMBC) Vol. 2018; pp. 1246 - 1249
Main Authors: Dhruba, Saugato Rahman, Rahmanl, Raziur, Matlockl, Kevin, Ghosh, Soupatno, Pal, Ranadip
Format: Conference Proceeding Journal Article
Language:English
Published: United States IEEE 01-07-2018
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Recent years have observed a number of Pharmacogenomics databases being published that enable testing of various predictive modeling techniques for personalized therapy applications. However, the consistencies between the databases are usually limited in spite of having significant number of common cell lines and drugs. In this article, we consider the problem of whether we can use the model learned from one secondary database to improve the prediction for the other target database. We illustrate using two pharmacogenomics databases that representing the databases using common basis vectors can improve prediction performance as compared to the naive application of a model trained on one database to another. We also elucidate the robustness of using PCA based basis vectors for scenarios with low correlated input features.
ISSN:1557-170X
1558-4615
DOI:10.1109/EMBC.2018.8512457